HAPPINESS BIOTECH GROUP LTD (HAPP) Social Stream



HAPPINESS BIOTECH GROUP LTD (HAPP): $4.50

0.06 (+1.35%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add HAPP to Watchlist
Sign Up

HAPPINESS DEVELOPMENT GROUP LTD (HAPP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HAPP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-04 1 $3 $3 $3 $4.5 -33.33%

Price Target Last Issued August 4, 2021

The Trend in the Analyst Price Target


HAPP's average price target has moved down $0 over the prior 16 days.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

HAPP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • HAPP has a greater number of analysts covering the stock than just about none of of all US stocks.
  • In terms of how HAPPINESS DEVELOPMENT GROUP LTD fares relative to all US stocks, note that its variance in analysts' estimates is lower than almost 100% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, HAPPINESS DEVELOPMENT GROUP LTD's upside potential (average analyst target price relative to current price) is greater than 0.97% of them.
  • HAPPINESS DEVELOPMENT GROUP LTD's average analyst price target is greater than 2.79% of Healthcare stocks.

In the Pharmaceutical Products industry, MDWD, NAII, and CYAN are the three stocks most similar to HAPPINESS DEVELOPMENT GROUP LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding HAPP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!